Specific chromosomal abnormalities in malignant human gliomas

S. H. Bigner, J. Mark, P. C. Burger, M. S. Mahaley, D. E. Bullard, L. H. Muhlbaier, D. D. Bigner

Research output: Contribution to journalArticle


Karyotypic analysis of 54 malignant human gliomas (5 anaplastic astrocytomas, 43 glioblastoma multiformes, 3 gliosarcomas, 2 giant cell glioblastomas, 1 anaplastic mixed glioma) has demonstrated that 12 tumors contained normal stemlines or only lacked one sex chromosome. The 42 tumors with abnormal karyotypes included 38 tumors which could be completely analyzed. Six of these 38 cases had near-triploid or near-tetraploid stemlines and 32 had near-diploid stemlines. Statistically significant numerical deviations in the near-diploid group were gains of chromosome 7 (26 of 32; P <0.001), and losses of chromosome 10 (19 of 32; P <0.001). Double minutes occurred in 18 of 32 near diploid tumors. The distribution of structural abnormalities was analyzed statistically by comparing the incidence of breakpoints in each chromosomal arm to the expected value based on chromosomal arm length. This analysis demonstrated that structural abnormalities of 9p and 19q were significant statistically (P <0.005 and P = 0.02, respectively). Although chromosome 1, 6p, the centrometric region of chromosome 11, 13q, and 15q were also frequently involved in structural abnormalities, the incidence of these breaks did not reach statistical significance. This demonstration of specific chromosomal abnormalities in near-diploid gliomas provides the basis for the investigation of genes which may be quantitatively or qualitatively altered in these neoplasms.

Original languageEnglish (US)
Pages (from-to)405-411
Number of pages7
JournalCancer Research
Issue number2
Publication statusPublished - 1988
Externally publishedYes


ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Bigner, S. H., Mark, J., Burger, P. C., Mahaley, M. S., Bullard, D. E., Muhlbaier, L. H., & Bigner, D. D. (1988). Specific chromosomal abnormalities in malignant human gliomas. Cancer Research, 48(2), 405-411.